Locations
Solna, Sweden · Stockholm, Sweden · Stockholm, Sweden
industry
Biotechnology · DeepTech
Size
51-200 employees
Stage
Series A
founded in
2023
Moleculent is focused on decoding the molecular foundation of biology through innovative technology that maps cell-cell communication. Their platform enables significant advancements in life sciences, particularly in understanding diseases like cancer and neurodegenerative disorders. By providing insights into cellular interactions within tissue environments, Moleculent aims to enhance drug response understanding and improve therapeutic strategies. Their commitment to data-driven, science-focused innovation positions them as a leader in functional proteomics, with the potential to transform diagnostics and treatment methodologies in the healthcare sector.
Something looks off?